A phase II trial of preoperative chemotherapy with capecitabine plus short-course radiotherapy for resectable T3 rectal cancer
Not Applicable
- Conditions
- resectable T3 rectal cancer
- Registration Number
- JPRN-UMIN000016518
- Lead Sponsor
- Meiwa Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1.Previous history of severe drug-induced allergy 2.Multiple malignancies to be treated or synchronous colorectal cancer 3. Active infections 4. Serious complications 5.Previous history of Interstitial Pneumonitis 6.Pleural effusion or ascites requiring treatment. 7. Active digestive tract bleeding 8. Severe watery diarrhea 9. Pregnant or nursing 10.Systemic administration of corticosteroids 11. Patients of hepatitis B virus suface antigen positivity 12.Contraindication of S-1or CPT-11 13. Patients judged inappropriate for this study by the physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method